Valuation: Carmat SA

Market Cap 61.46L 69.97L 56.62L 52.94L 99.3L 66Cr 1.01Cr 6.79Cr 2.63Cr 33Cr 2.63Cr 2.57Cr 113.1Cr P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 5.92Cr 6.74Cr 5.46Cr 5.1Cr 9.57Cr 636.44Cr 9.75Cr 65Cr 25Cr 313.73Cr 25Cr 25Cr 1.09TCr EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Current year 0.1
Extreme 0.099
0.1
1 year 0.08
Extreme 0.085
0.83
3 years 0.08
Extreme 0.085
9.99
5 years 0.08
Extreme 0.085
31.7
10 years 0.08
Extreme 0.085
44.95
Manager TitleAgeSince
Chief Executive Officer 55 01/09/2016
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/04/2025
Director TitleAgeSince
Chairman 71 25/06/2024
Director/Board Member 63 07/05/2021
Director/Board Member 79 20/04/2017
Date Insider Type Main position Quantity % Market Cap.
13/25/13Sell

Chairman

13,43,333 2.3347%
13/25/13Buy

Chairman

13,43,333 2.3347%
29/24/29Buy

Director

13,43,333 4.6122%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-70.09%-98.62% 70.8L
+0.77%+2.70%-19.41%+6.12% 12TCr
-0.56%+1.19%+4.51%-7.28% 1.28TCr
+3.49%+9.10%+43.56%+111.31% 836.97Cr
+0.95%-2.64%-48.91%-71.79% 394.52Cr
-0.83%-0.59%+17.21%+37.73% 252.74Cr
-5.16%-4.93%-20.70%-17.36% 167.93Cr
+3.08%+21.07%+250.54%+185.59% 169.97Cr
-0.87%-0.70%-0.12%-20.99% 157.47Cr
Average +0.10%+2.12%+17.40%+13.85% 1.71TCr
Weighted average by Cap. +0.73%+2.75%-10.97%+10.69%

Financials

2023 2024
Net sales 38.37L 43.68L 35.35L 33.05L 62L 41Cr 63.13L 4.24Cr 1.64Cr 20Cr 1.64Cr 1.6Cr 71Cr 73.44L 83.61L 67.66L 63.27L 1.19Cr 79Cr 1.21Cr 8.12Cr 3.14Cr 39Cr 3.14Cr 3.07Cr 135.15Cr
Net income -5.39Cr -6.13Cr -4.96Cr -4.64Cr -8.7Cr -578.68Cr -8.86Cr -60Cr -23Cr -285.26Cr -23Cr -23Cr -991.31Cr -5.14Cr -5.85Cr -4.74Cr -4.43Cr -8.3Cr -552.1Cr -8.46Cr -57Cr -22Cr -272.16Cr -22Cr -21Cr -945.79Cr
Net Debt 4.96Cr 5.65Cr 4.57Cr 4.28Cr 8.02Cr 533.21Cr 8.17Cr 55Cr 21Cr 262.84Cr 21Cr 21Cr 913.42Cr 5.31Cr 6.05Cr 4.89Cr 4.57Cr 8.58Cr 570.42Cr 8.74Cr 59Cr 23Cr 281.18Cr 23Cr 22Cr 977.16Cr
Logo Carmat SA
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153
  1. Stock Market
  2. Stocks
  3. ALCAR Stock